ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2026
Metal Chelation Following Inappropriate Testing: Approach to Non-Medically Indicated Therapy Requests : Ethics in Practice.
Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Requests for chelation therapy following inappropriate or scientifically unsound testing in medical toxicology practice raise important ethical tensions between patient autonomy, professional integrity, and the therapeutic relationship. The central tension is how medical toxicologists should respond when patients strongly request non-medically indicated therapies that lack evidence of benefit and carry potential risk. We argue that while respect for patient autonomy requires earnest engagement with patient concerns, it does not obligate physicians to provide therapies they believe are scientifically unsupported or potentially harmful. Ethical care in these situations requires balancing patient autonomy with nonmaleficence and responsibilities to preserve professional integrity and public trust. Patients pursuing alternative therapies are sometimes motivated by prior experiences of dismissal, unresolved symptoms, and distrust of conventional medicine. Reflexive refusal or adversarial communication may further erode trust and increase the likelihood of patients pursuing unsafe therapies elsewhere. We propose that medical toxicologists should approach these encounters with transparent communication, acknowledgment of medical uncertainty and patient suffering, and continued therapeutic engagement even when declining requested treatment. Maintaining a therapeutic alliance while avoiding non-indicated interventions is challenging in practice but promotes long-term patient health and preserves trust, both between physician and patient and between the public and profession of medical toxicology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.